Back
The E W Scripps Vs. Spyre Therapeutics Industry Stock Comparison
Sell
47
SSP
The E W Scripps
Last Price:
2.58
Seasonality Move:
11.63%
Sell
27
SYRE
Spyre Therapeutics
Last Price:
23.95
Seasonality Move:
49.76%
Sell
47
The E W Scripps (SSP)
is a Sell
Is The E W Scripps a Buy, Sell or Hold?
- The current The E W Scripps [SSP] share price is $2.64. The Score for SSP is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- SSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SSP Stock Price Chart
What is The E W Scripps's stock price today?
-
The The E W Scripps share price today is $2.64
The current trend is relatively stagnant and SSP is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $22.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
SSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 50.12 | Buy |
Chaikin Money Flow: | 231840 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.23 - 2.81) | Buy |
Bollinger Bands (100): | (2.59 - 5.17) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 28.27 | Sell |
Chaikin Money Flow: | -408420 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.66 - 36.8) | Sell |
Bollinger Bands (100): | (27.1 - 39.22) | Sell |
SSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.25 | Buy |
20-day SMA: | 2.45 | Buy |
50-day SMA: | 3.13 | Sell |
200-day SMA: | 5.41 | Sell |
8-day EMA: | 2.39 | Buy |
20-day EMA: | 2.51 | Buy |
50-day EMA: | 3.05 | Sell |
200-day EMA: | 5.34 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.49 | Sell |
20-day SMA: | 31.58 | Sell |
50-day SMA: | 33.73 | Sell |
200-day SMA: | 24.46 | Sell |
8-day EMA: | 26.49 | Sell |
20-day EMA: | 30.15 | Sell |
50-day EMA: | 32.53 | Sell |
200-day EMA: | 27.05 | Sell |
The E W Scripps Earnings Growth & SSP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.80 per share, and a decrease next year of $1.02 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
The E W Scripps Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |